• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CLARE DISCRETE MFG IO ACCESS SARS-COV-2 ANTIGEN; IN VITRO DIAGNOSTIC DEVICES: CORONAVIRUS SEROLOGICAL REAGENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CLARE DISCRETE MFG IO ACCESS SARS-COV-2 ANTIGEN; IN VITRO DIAGNOSTIC DEVICES: CORONAVIRUS SEROLOGICAL REAGENTS Back to Search Results
Catalog Number C68668
Device Problem False Positive Result (1227)
Patient Problem Insufficient Information (4580)
Event Date 04/28/2021
Event Type  malfunction  
Manufacturer Narrative
The full identifier is (b)(6).The customer did not provide patient demographics such as age, date of birth, sex, weight, ethnicity or race.The access sars-cov-2 antigen assay was not returned for evaluation.There were no reports of system issues at the time of the event.No hardware errors or flags were reported in conjunction with the event.System performance indicators such as system check and calibration passing within specifications.No issues with sample integrity were reported by the customer.In conclusion, the cause of this event cannot be determined with the available information.
 
Event Description
On (b)(6) 2021 the customer reported reactive beckman covid antigen patient results (access sars-cov-2 antigen, part number c68668 and lot number 971260) were generated on the customer's access 2 (access 2 immunoassay analyzer, part number 81600n and serial number (b)(4)).The customer reported a total of two (2) patients samples were reactive with the beckman covid antigen test while results with the biofire respiratory panel 2.1 (pcr methodology) were non-reactive.The customer indicated the results were reported out of the laboratory but were questioned by the physician.The customer did not report a change to patient care of treatment in connection with this event.No hardware errors or issues with other assays were reported in conjunction with this event.System performance indicators such as system check and calibration were passing within specifications at the time of the event.Although it was noted that the quality control (qc) level 2 had a "qcf" (qc fail) flag, there is insufficient information to reasonably suggest a use error or reagent malfunction was the cause of the qc failure.No issues with sample integrity were reported by the customer.The customer reported remel microtest tubes were used for transport media.The customer reported mantacctm flocked swabs used by miraclean technology are used for specimens.No issues were reported with the swabs.
 
Manufacturer Narrative
Bec tracking number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCESS SARS-COV-2 ANTIGEN
Type of Device
IN VITRO DIAGNOSTIC DEVICES: CORONAVIRUS SEROLOGICAL REAGENTS
Manufacturer (Section D)
CLARE DISCRETE MFG IO
lismeehan
o'callaghans mills
EI 
MDR Report Key11873992
MDR Text Key252352782
Report Number9680746-2021-00039
Device Sequence Number1
Product Code QKO
UDI-Device Identifier15099590742713
UDI-Public(01)15099590742713(17)210608(11)201210(10)971260
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date 08/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/25/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/08/2021
Device Catalogue NumberC68668
Device Lot Number971260
Was Device Available for Evaluation? No
Date Manufacturer Received06/25/2021
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberZ-2255-2021
Patient Sequence Number1
-
-